Dietary n-6 polyunsaturated fatty acids (PUFAs) promote rat mammary cancer while n-3 PUFAs are inhibitory. The purpose of this study was to determine whether the fats exert their effects by altering the expression of genes that affect cancer development. Therefore, we have examined the effect of PUFAs on the expression of the cyclooxygenase (COX) 1 and 2 genes that are involved in prostaglandin biosynthesis. We also investigated the effect of dietary PUFAs on the expression of the p21 ras protein and Ha-ras mRNA. Rats were fed either low-(7%; LF) or high-(21%; HF) fat diets that were rich in either n-6 PUFAs (safflower oil, S) or n-3 PUFAs (menhaden oil, M) for 3 weeks. COX-1 mRNA levels were approximately the same in groups fed diets containing either level of menhaden oil, but were increased by~30% in the LFS and HFS groups (P Ͻ 0.05). Transcripts of the inducible COX-2 gene were not detectable in the menhaden oil groups, but this gene was expressed in animals fed either level of safflower oil and in the HFS group was associated with increased levels of COX enzymatic activity and production of PGE 2 . Animals fed safflower oil had elevated levels of p21 ras protein compared to animals fed menhaden oil. Ha-ras mRNA was increased by~35% in animals fed HFS compared to the group fed HFM (P < 0.05). These results demonstrate that dietary n-6 PUFAs upregulate COX-2 and, to some extent, COX-1 expression. There was a concomitant increase in COX enzyme activity and PG synthesis in the mammary glands of rats fed high levels of n-6 PUFAs. Together with associated changes in p21 ras expression, these results may explain, at least in part, the promoting effects of dietary n-6 PUFAs on mammary carcinogenesis.
Introduction
Dietary fats are known to modulate mammary gland carcinogenesis in experimental animals (1, 2) and may have similar effects in human breast cancer development (3) . Several studies in rodents have shown that vegetable oils rich in n-6 polyunsaturated fatty acids (PUFAs*) promote mammary carcinogenesis whereas similar levels of marine oils rich in n-3 PUFAs, appear to inhibit (1, 4) . A number of mechanisms have been suggested to explain the association between dietary fatty acids and breast cancer (for review see ref. 5 ). Among these, particular attention has been paid to their effects on prostaglandin (PG) synthesis (6) .
It is well known that malignant breast tumours and tumour cell lines from humans and rodents contain elevated levels of PGs compared to the normal tissues from which they arise (7) (8) (9) . Inhibiting PG synthesis by non-steroidal antiinflammatory drugs (NSAIDs) has been shown to hinder the development of chemically-induced as well as transplantable mammary cancer (10) (11) (12) (13) . Evidence linking the effects of dietary fat on mammary carcinogenesis to PG synthesis derives mainly from the observation that NSAIDs inhibit the promoting effects of diets rich in n-6 PUFAs (10, 14) . Furthermore, the n-6 PUFA linoleic acid (LA) is a precursor of the PG 2 series that are known to be mitogenic for normal human and rodent mammary epithelial cells (6) . On the other hand, the n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are precursors of the PG 3 series that lack such a mitogenic effect. Associations have also been made between dietary fatty acids, PG synthesis and ras gene expression (8) . The Ha-ras gene is commonly mutated in rat mammary adenocarcinomas and is over expressed in many human breast cancers (for review see ref. 15) .
The key regulatory enzyme in PG biosynthesis is prostaglandin H-synthase/cyclooxygenase (COX) that catalyses the conversion of arachidonic acid (AA) to PGs (16) . There are two COX isoforms, COX-1 and COX-2, both of which are usually inhibited by NSAIDs. In order to provide further information on the mechanism by which dietary fats modulate breast cancer development, the present study examines the effect of feeding rats different levels of n-3 and n-6 PUFAs on the expression of the COX-1 and COX-2 genes, as well as the Ha-ras gene in mammary glands.
Materials and methods

Animals and diets
Pathogen-free female Sprague-Dawley rats (38-43 days old) purchased from Charles River Laboratories (St Constant, Quebec, Canada) were housed at 24 Ϯ 2°C and 50% humidity, with a 12-h light/dark cycle. They were acclimatized for 7 days with food and water provided ad libitum. The animals were then randomized into four groups (five per group) and were fed one of four experimental diets for 3 weeks. The composition of the experimental diets is shown in Table I . The diets, purchased from Dyets Co. (Bethlehem, PA), were based on the American Institute of Nutrition standard reference diet AIN-93G (17) with the addition of menhaden oil or safflower oil at the expense of carbohydrate (Table I) . Soybean oil was added at 1 or 3% to the low and high fat diets, respectively, to provide essential fatty acids. All diets were stored in dark, air-tight containers at 4°C. Animals were killed by cervical dislocation, and mammary tissues were frozen in liquid N 2 and stored at Ϫ80°C. Northern analysis of COX-1 and Ha-ras mRNA Total RNA (20-25 µg) from the mammary glands of individual rats, isolated by the TRIzol reagent (Life Technologies; Grand Island, NY), was subjected to Northern blot analysis (18) using Zeta-Probe nylon membranes (Bio-Rad; Hercules, CA). The hybridization solution contained 50-100 ng of the probe labelled with [α 32 P]dCTP using random hexamer priming (Ambion Co., Austin, TX) to a specific activity of~10 8 c.p.m./µg. The probe for the Haras gene was the 460 bp EcoRI fragment from plasmid BS9 described previously (19) . The murine COX-1 probe was a 1.7 kb DNA fragment containing the coding sequences, but not the 5Ј and 3Ј untranslated flanking sequences (Oxford Biomedical Research, Oxford, MI). Following hybridization and autoradiography, membranes were rehybridized to a 32 P-labelled β-actin probe (19) to verify equal RNA loading. Autoradiograms were scanned with an Ultrascan XL laser densitometer (LKB, Washington, DC), and signals were integrated and normalized to the corresponding level of β-actin.
RT-PCR analysis of COX-2 mRNA
We used PCR primers that have already been described for COX-2 and GAPDH (20) (COX-2 5Ј primer CTGTATCCCGCCCTGCTGGTG, 3Ј primer ACTTGCGTTGATGGTGGCTGTCTT; GAPDH 5Ј primer CCTTCATTGA-CCTCAACTAC, 3Ј primer GGAAGGCCATGCCAGTGAGC). These primer pairs yield amplified products of 279 bp for COX-2 and 574 bp for GAPDH. Total RNA (1 µg) was converted to single-stranded cDNA using 50U of MMLV-reverse transcriptase with 2.5 µM random hexamers. cDNA samples were split into two equal aliquots and amplified using 0.2 µM primers. The cycling programme was an initial 5 min for melting (94°C) followed by 30 cycles of melting (94°C, 1 min), annealing (55°C, 1 min) and extension (72°C, 1 min), and a final extension step (72°C, 10 min). PCR products were separated in 2% agarose gels and visualized by ethidium bromide staining. We ran controls to rule out contamination of RNA with genomic DNA in which reverse transcriptase was omitted from the reaction mixtures. To rule out other sources of contamination, control PCR reactions were carried out in reaction mixtures containing no cDNA.
Western blotting of p21 ras protein Mammary glands were homogenized in ice-cold PBS with 0.2 mM PMSF and 0.1 mM leupeptin using a Polytron homogenizer at high speed for 10 s.
Homogenates were centrifuged at 800 g for 10 min and supernatants centrifuged at 40 000 g for 30 min. Plasma membranes were solubilized in homogenization buffer containing 10 mM sodium-deoxycholate and 1% Triton X-100 then centrifuged at 40 000 g for 30 min. Equivalent amounts of protein were applied to 12.5% SDS-polyacrylamide gels, separated by electrophoresis and electrotransferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA). Membranes were blocked with 5% non-fat dry milk and probed with a pan-reactive anti-ras monoclonal antibody (Oncogene Science, Cambridge, MI) in 1% non-fat dry milk. After incubation with a peroxidase-conjugated anti-mouse antibody (Sigma Chemicals, Oakville, ON), signals were detected by enhanced chemiluminescence (Amersham, Arlington Heights, IL).
COX enzymatic activity
Mammary glands from individual animals were homogenized in 100 mM Tris-HCl buffer (pH 7.4) and centrifuged at 9000 g at 4°C for 15 min. The supernatant was then centrifuged at 100 000 g for 1 h and the resulting microsomal fraction was resuspended in 50 mM potassium phosphate buffer (pH 7.4). COX activity was assayed essentially as described previously (21 2 Analysis of the mammary gland PGE 2 was performed as described earlier (23) . Briefly, tissues (200-300 mg) were minced, sonicated in 0.1 M TrisHCl buffer (pH 7.4), and centrifuged at 800 g for 15 min to separate cell debris and the fat layer. The resulting supernatant was acidified to pH 3.5 with glacial acetic acid and extracted three times with 3 vol of ethyl acetate. Extracts were combined, evaporated to dryness under N 2 , resuspended in 200 µl of the enzyme immunoassay (EIA) buffer and stored at Ϫ80°C until analysed. EIA was carried out using a Correlate-EIA kit (Assay Designs Inc., Ann Arbor, MI). Colour intensity was measured at 405 nm using a Bio-Rad 550 microplate reader and the levels of PGE 2 were expressed as ng/g wet tissue. Figure 1a (upper panel) shows a representative Northern blot of COX-1 mRNA isolated from the mammary glands of rats fed diets containing different levels of menhaden oil or safflower oil for 3 weeks. The 2.7 kb transcripts from five animals per group were quantified in arbitrary density units (ADU) relative to the intensity of the corresponding β-actin band. As shown in Figure 2 , the expression of COX-1 mRNA was not changed in groups fed low fat menhaden (LFM) or high fat menhaden (HFM). Groups fed safflower oil at either level, however, had small, but significant increases in COX-1 expression (~35%; P Ͻ 0.05) when compared to either the low or high fat menhaden oil group. Since we were unable to detect COX-2 mRNA by Northern analysis due to its absence or low abundance in normal tissues (24-26), we used RT-PCR to detect this transcript in the mammary tissues. COX-2 mRNA was undetectable in the mammary glands of the groups fed either level of menhaden oil, but the gene was clearly expressed in groups fed safflower oil (Figure 1b) . Figure  1b is a representative blot of COX-2 transcripts from one animal per dietary group, but the same pattern of expression was obtained in four sets of samples. COX enzymatic activity and levels of PGE 2 COX enzymatic activities were analysed by measuring the conversion rate of [1-14 C]AA to prostanoids using a previously published radio-TLC technique (21, 22) . As shown in Table II , animals fed HFM had significantly lower COX activity in the mammary glands than those fed LFM. The group fed HFS had a significantly higher level of COX activity than that fed HFM. We next measured the concentration of mammary gland PGE 2 by enzyme immunoassay (Table II) . There was generally a good correlation between changes in COX activity and the concentration of PGE 2 in the corresponding groups (r ϭ 0.64, P Ͻ 0.05). Figure 1a (middle panel) shows a representative Northern blot of Ha-ras mRNA from mammary glands of rats fed the four diets. The 1.4 kb transcripts from five animals per group from each group were quantified in ADU by measuring band intensities relative to the intensity of the corresponding β-actin bands. As shown in Figure 3b , Ha-ras mRNA only showed a significant increase in animals fed HFS (~35%, PϽ0.05). Levels of immunodetectable p21 ras were higher in the animals fed both levels of safflower oil compared to those fed menhaden oil as shown in the Western blot in Figure 3a .
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Discussion
In an effort to elucidate the mechanisms by which dietary fat modulates carcinogenesis in rat mammary glands, we have examined the effect of diets rich in n-3 and n-6 PUFAs on the expression of the COX-1 and COX-2 genes and the Ha-ras proto-oncogene. The experimental diets were based on the AIN-93G standard reference diet (17) . The 7% soybean oil in the AIN-93G diet was replaced by 1% soybean oil (to ensure adequate amounts of LA) plus either 6% menhaden oil or safflower oil in the low fat diets, or 3% soybean oil plus either 18% menhaden oil or safflower oil in the high fat diets (Table I ). In the high fat diets, the oils were added at the expense of carbohydrates such that the caloric density of the high fat diet was 416 kcal/100 g compared to 360 kcal/100 g for the low fat diet. Menhaden oil and safflower oil are rich sources of n-3 and n-6 PUFAs, respectively. The average body weights of the animals in the four dietary groups were not different at the time of sacrifice.
COX-1 is constitutively expressed in many tissues (24), although several studies have shown that its level of expression can vary with the state of differentiation or following cytokine or tumour promoter stimulation (27) (28) (29) (30) . In contrast, COX-2 is normally not expressed in most tissues, but its expression in certain cell types can be rapidly induced by various mitogens, hormones and growth factors (31) . Our results demonstrate that animals fed safflower oil have small, but significant increases in COX-1 expression compared to animals fed menhaden oil. Moreover, although no COX-2 expression could be detected in the mammary glands of the animals fed menhaden oil, transcripts of the gene were clearly present in groups fed safflower oil. These observations indicate that n-6 PUFAs are able to increase the expression of both COX-1 and COX-2 in rat mammary glands, whereas n-3 PUFAs do not possess this ability. Although in the present study we used preparations from normal mammary tissue, similar changes may be expected to occur in preneoplastic mammary epithelial cells.
In the present study, increased expression of COX-1 and COX-2 in the mammary glands of animals fed HFS compared to those fed HFM was accompanied by elevated COX enzymatic activities and levels of PGE 2 . Increases in COX enzymatic activity with concomitant enhanced capacity of cells to produce PGs may occur via increases in the transcription of the cyclooxygenase genes (16, 27, 28, 32) . Specifically, several studies suggest that elevated levels of PGE 2 are produced by increased expression of COX-2 (32) (33) (34) . However, COX-2 mRNA was induced in animals fed LFS compared to those fed LFM with no accompanying elevation in COX enzymatic 908 activity or PGE 2 levels. The discrepancy between COX-2 mRNA levels and COX enzymatic activity in the high fat and low fat groups is likely to be due to differences in the stability of the mRNA. It is known that COX-2 mRNA is highly unstable (35) , but its stability can be increased by factors known to increase PG synthesis such as interleukin (IL)-1α (36), IL-1β (37) and transforming growth factor-β (28) . Furthermore, several studies have shown elevated accumulation, increased stability and accelerated post-transcriptional processing of various genes expressed in the mammary glands of animals fed high fat compared to low fat diets (38) (39) (40) (41) .
We observed significant reductions in both COX activity and PGE 2 levels in animals fed HFM compared to LFM. This is likely to be because EPA and DHA are not oxygenated as rapidly as AA and act as competitive inhibitors of COX endoperoxide activity (42) . Our results agree with those of Karmali et al. (8) who reported that dietary n-3 PUFAs were associated with lower levels of PGE 2 in normal and cancerous mammary glands from DMBA-treated rats compared to dietary n-6 PUFAs.
PG biosynthesis, particularly series 2, can stimulate cell proliferation and suppress the immune response and may thereby promote cancer development (43) . Overproduction of PGs has been reported to occur in human breast cancers as well as in rat mammary adenocarcinomas (7) (8) (9) , and has been suggested to play a role in mammary carcinogenesis (32) . Recently, Tsuji and DuBois (44) examined the possible role of COX-2 in carcinogenesis using stably transfected rat intestinal epithelial cells overexpressing this gene. Interestingly, these cells had elevated Bcl2 protein expression, reduced transforming growth factor-β2 receptor levels and were resistant to apoptosis. Furthermore, the cells had elevated E-cadherin levels and increased adhesion to extracellular matrix proteins. Both phenotypic changes were reversed by sulindac sulphide, a COX inhibitor. As suggested by the authors, the phenotypic changes induced in these epithelial cells by COX-2 over expression could enhance their tumourigenic potential. In a similar manner, COX-2 induction by n-6 PUFAs that we observed in the mammary gland, might lead to enhanced persistence of preneoplastic cells.
In contrast to the effects of n-6 PUFAs, n-3 PUFAs have been shown to inhibit the growth of human breast cancer cells (45, 46) . These effects were attributed to the production of series 3 PGs, rather than series 2 and also to the ability of metabolites of the n-3 PUFAs to inhibit the metabolism of n-6 PUFAs at various stages in the AA cascade. The findings of the present study suggest that the inhibitory effect of n-3 PUFAs on mammary carcinogenesis might be due to their modulating effects on COX enzymatic activity.
Our results suggest, furthermore, that the tumour promoting activity of n-6 PUFAs may be related to their ability to increase levels of p21 ras . The increases we observed in p21 ras in the LFS and HFS groups compared to those fed LFM or HFM are in general agreement with those of Karmali et al. (8) who reported higher levels of p21 ras in mammary tumours from DMBA-treated Sprague-Dawley rats fed corn oil compared to those fed fish oil. In their study, p21 ras levels were not different in normal mammary tissues taken from these two groups of tumour-bearing animals. Telang et al. (47) , however, reported increased levels of p21 ras in murine mammary explant cultures harbouring preneoplastic hyperplastic alveolar nodules after treatment with n-6 PUFAs and decreased p21 ras levels in these cultures treated with n-3 PUFAs.
The Ha-ras gene is commonly mutated in rat mammary adenocarcinomas and is over expressed in many human breast cancers (15, 19, 48) . In the present study, however, increases in p21 ras in the LFS and HFS groups were only accompanied by a significant increase in Ha-ras mRNA in the HFS group. This may be due to the involvement of the Ki-or N-ras genes or to the complexities of the post-translational modification of p21 ras (49, 50) .
The correlation we have observed between dietary fatty acids and p21 ras and PG levels in the mammary gland suggests a mechanistic association. Indeed, phospholipase A 2 (PLA 2 ) has been shown to be stimulated by activated ras (50) . PLA 2 -mediated phospholipid hydrolysis can release arachidonic acid that can subsequently be converted into PGs. This suggests that ras is a primary control point for PG synthesis. In support of this suggestion, mammary epithelial cells transfected with the Ha-ras gene exhibit enhanced transcription of COX-2 and increased production of PGE 2 (51) . Moreover, factors that alter ras farnesylation can modulate the expression of the COX-2 gene (52) .
In summary, we have shown that dietary n-6 PUFAs upregulate COX-2 and, to some extent, COX-1 expression. There was a concomitant increase in COX enzyme activity and PG synthesis in the mammary glands of rats fed high levels of n-6 PUFAs. Together with associated changes in p21 ras expression, these results may explain, at least in part, the promoting effects of dietary n-6 PUFAs on mammary carcinogenesis.
